Thomas Verissimo

644 total citations
19 papers, 358 citations indexed

About

Thomas Verissimo is a scholar working on Molecular Biology, Nephrology and Transplantation. According to data from OpenAlex, Thomas Verissimo has authored 19 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Nephrology and 3 papers in Transplantation. Recurrent topics in Thomas Verissimo's work include Chronic Kidney Disease and Diabetes (5 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Dialysis and Renal Disease Management (3 papers). Thomas Verissimo is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Dialysis and Renal Disease Management (3 papers). Thomas Verissimo collaborates with scholars based in Switzerland, United States and Canada. Thomas Verissimo's co-authors include Sophie de Seigneux, David Legouis, Anna Faivre, Jérôme Pugin, Maarten Naesens, Lena Berchtold, Pietro E. Cippà, Eric Féraille, Kari Koppitch and Sandrine Placier and has published in prestigious journals such as Critical Care Medicine, Cell Reports and American Journal of Physiology-Renal Physiology.

In The Last Decade

Thomas Verissimo

19 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Verissimo Switzerland 9 130 124 46 44 43 19 358
Qunzi Zhang China 12 135 1.0× 196 1.6× 75 1.6× 28 0.6× 46 1.1× 20 488
Hye‐Myung Ryu South Korea 10 145 1.1× 112 0.9× 43 0.9× 27 0.6× 19 0.4× 14 328
Seiko Hoshino Japan 12 119 0.9× 187 1.5× 53 1.2× 19 0.4× 46 1.1× 23 395
John Hartono United States 6 168 1.3× 169 1.4× 64 1.4× 20 0.5× 64 1.5× 8 416
Fatemeh Hayati Iran 10 87 0.7× 172 1.4× 70 1.5× 25 0.6× 24 0.6× 26 385
Bei Wu China 7 160 1.2× 148 1.2× 45 1.0× 14 0.3× 25 0.6× 35 369
Carolina Hernández-Carballo Spain 9 97 0.7× 185 1.5× 76 1.7× 32 0.7× 34 0.8× 17 415
Ariane Duval-Sabatier France 7 122 0.9× 241 1.9× 49 1.1× 20 0.5× 33 0.8× 10 442
Mariusz L. Kielar United States 9 98 0.8× 171 1.4× 112 2.4× 79 1.8× 17 0.4× 16 450

Countries citing papers authored by Thomas Verissimo

Since Specialization
Citations

This map shows the geographic impact of Thomas Verissimo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Verissimo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Verissimo more than expected).

Fields of papers citing papers by Thomas Verissimo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Verissimo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Verissimo. The network helps show where Thomas Verissimo may publish in the future.

Co-authorship network of co-authors of Thomas Verissimo

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Verissimo. A scholar is included among the top collaborators of Thomas Verissimo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Verissimo. Thomas Verissimo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Faivre, Anna, Thomas Verissimo, & Sophie de Seigneux. (2025). Proteinuria and tubular cells: Plasticity and toxicity. Acta Physiologica. 241(2). e14263–e14263. 2 indexed citations
2.
Demarchi, Marco Stefano, Thomas Verissimo, Marylise Fernandez, et al.. (2025). Primary hyperparathyroidism induces erythropoietin resistance through fibroblast growth factor 23. European Journal of Endocrinology. 192(3). 290–298. 2 indexed citations
3.
Legouis, David, Anna Maria Rinaldi, Thomas Verissimo, et al.. (2024). A transfer learning framework to elucidate the clinical relevance of altered proximal tubule cell states in kidney disease. iScience. 27(3). 109271–109271. 4 indexed citations
4.
Verissimo, Thomas, et al.. (2023). Gluconeogenesis in the kidney: in health and in chronic kidney disease. Clinical Kidney Journal. 16(8). 1249–1257. 21 indexed citations
5.
Verissimo, Thomas, Anna Faivre, Soline Bourgeois, et al.. (2023). PCK1 is a key regulator of metabolic and mitochondrial functions in renal tubular cells. American Journal of Physiology-Renal Physiology. 324(6). F532–F543. 28 indexed citations
6.
Verissimo, Thomas & Sophie de Seigneux. (2023). New evidence of the impact of mitochondria on kidney health and disease. Nature Reviews Nephrology. 20(2). 81–82. 3 indexed citations
7.
Verissimo, Thomas, et al.. (2023). Thiamine as a metabolic resuscitator in septic shock: a meta-analysis of randomized controlled trials with trial sequential analysis. Frontiers in Medicine. 10. 1223862–1223862. 3 indexed citations
8.
Verissimo, Thomas, Anna Faivre, Sebastian Sgardello, et al.. (2022). Estimated Renal Metabolomics at Reperfusion Predicts One-Year Kidney Graft Function. Metabolites. 12(1). 57–57. 3 indexed citations
9.
Assouline, Benjamin, Anna Faivre, Thomas Verissimo, et al.. (2021). Thiamine, Ascorbic Acid, and Hydrocortisone As a Metabolic Resuscitation Cocktail in Sepsis: A Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis*. Critical Care Medicine. 49(12). 2112–2120. 35 indexed citations
10.
Faivre, Anna, et al.. (2021). Tubular Cell Glucose Metabolism Shift During Acute and Chronic Injuries. Frontiers in Medicine. 8. 742072–742072. 37 indexed citations
11.
Campion, Carole G., et al.. (2021). Does Subtelomeric Position of COMMD5 Influence Cancer Progression?. Frontiers in Oncology. 11. 642130–642130. 3 indexed citations
12.
Legouis, David, Anna Faivre, Thomas Verissimo, et al.. (2020). Altered proximal tubular cell glucose metabolism during acute kidney injury is associated with mortality. Nature Metabolism. 2(8). 732–743. 106 indexed citations
13.
Verissimo, Thomas, et al.. (2020). Measured and Estimated Glomerular Filtration Rate in the ICU: A Prospective Study. Critical Care Medicine. 48(12). e1232–e1241. 27 indexed citations
14.
Faivre, Anna, Elena Katsyuba, Thomas Verissimo, et al.. (2020). Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease. Nephrology Dialysis Transplantation. 36(1). 60–68. 43 indexed citations
15.
Verissimo, Thomas, Anna Faivre, Lena Berchtold, et al.. (2020). Kinetic GFR Outperforms CKD-EPI for Slow Graft Function Prediction in the Immediate Postoperative Period Following Kidney Transplantation. Journal of Clinical Medicine. 9(12). 4003–4003. 3 indexed citations
16.
Campion, Carole G., Kossay Zaoui, Thomas Verissimo, et al.. (2018). COMMD5/HCaRG Hooks Endosomes on Cytoskeleton and Coordinates EGFR Trafficking. Cell Reports. 24(3). 670–684.e7. 18 indexed citations
17.
Matsuda, Hiroyuki, Carole G. Campion, Kyoko Fujiwara, et al.. (2017). HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma. Oncotarget. 8(41). 69559–69576. 18 indexed citations
18.
Tremblay, Johanne, et al.. (2016). OS 36-01 HCaRG IMPROVES TISSUE REPAIR AFTER RENAL INJURY BY REGULATING EGFR SIGNALING. Journal of Hypertension. 34(Supplement 1). e402–e402. 1 indexed citations
19.
Verissimo, Thomas, et al.. (2016). O Método nas Pesquisas Sobre a Responsividade de Escalas que Avaliam Doenças Neurológicas. 16(1). 17–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qunzi Zhang Breakdown of academic impact, for papers by Hye‐Myung Ryu Breakdown of academic impact, for papers by Seiko Hoshino Breakdown of academic impact, for papers by John Hartono Breakdown of academic impact, for papers by Fatemeh Hayati Breakdown of academic impact, for papers by Bei Wu Breakdown of academic impact, for papers by Carolina Hernández-Carballo Breakdown of academic impact, for papers by Ariane Duval-Sabatier Breakdown of academic impact, for papers by Mariusz L. Kielar
Rankless by CCL
2026